Evidence map›Paper›PMID 32300106›Full record

ArticleNature communications2020

Author Correction: Exploring use of unsupervised clustering to associate signaling profiles of GPCR ligands to clinical response.

Besma Benredjem, Jonathan Gallion, Dennis Pelletier, Paul Dallaire, Johanie Charbonneau, Darren Cawkill, Karim Nagi, Mark Gosink, Viktoryia Lukasheva, Stephen Jenkinson and 9 more

Abstract readPublished Erratum
In one paragraph

Article in Nature communications, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

19 authors.

Besma Benredjem *Department of Pharmacology and Physiology, Faculty of Medicine, Université de Montréal, Montréal, QC, H3T 1J4, Canada.
Jonathan Gallion *Baylor College of Medicine, Houston, TX, 77030, USA.
Dennis PelletierPfizer Inc, Groton, CT, 06340, USA.
Paul DallaireDepartment of Pharmacology and Physiology, Faculty of Medicine, Université de Montréal, Montréal, QC, H3T 1J4, Canada.
Johanie CharbonneauCHU Sainte-Justine Research Center, Montréal, QC, H3T 1C5, Canada.
Darren CawkillPfizer Inc, Groton, CT, 06340, USA.
Karim NagiCollege of Medicine, Member of QU Health, Qatar University, Doha, Qatar.ORCID http://orcid.org/0000-0002-4700-5568
Mark GosinkPfizer Inc, Groton, CT, 06340, USA.
Viktoryia LukashevaInstitute for Research in Immunology and Cancer, Department of Biochemistry and Molecular Medicine, Université de Montréal, Montréal, QC, H3T 1J4, Canada.
Stephen JenkinsonPfizer Inc, Groton, CT, 06340, USA.
Yong RenPfizer Inc, Groton, CT, 06340, USA.
Christopher SompsPfizer Inc, Groton, CT, 06340, USA.
Brigitte MuratInstitute for Research in Immunology and Cancer, Department of Biochemistry and Molecular Medicine, Université de Montréal, Montréal, QC, H3T 1J4, Canada.
Emma Van Der WesthuizenInstitute for Research in Immunology and Cancer, Department of Biochemistry and Molecular Medicine, Université de Montréal, Montréal, QC, H3T 1J4, Canada.ORCID http://orcid.org/0000-0001-9165-8526
Christian Le GouillInstitute for Research in Immunology and Cancer, Department of Biochemistry and Molecular Medicine, Université de Montréal, Montréal, QC, H3T 1J4, Canada.
Olivier LichtargeBaylor College of Medicine, Houston, TX, 77030, USA.
Anne SchmidtPfizer Inc, Groton, CT, 06340, USA.
Michel BouvierInstitute for Research in Immunology and Cancer, Department of Biochemistry and Molecular Medicine, Université de Montréal, Montréal, QC, H3T 1J4, Canada. michel.bouvier@umontreal.ca.ORCID http://orcid.org/0000-0003-1128-0100
Graciela PineyroDepartment of Pharmacology and Physiology, Faculty of Medicine, Université de Montréal, Montréal, QC, H3T 1J4, Canada. graciela.pineyro.filpo@umontreal.ca.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Identifiers

PMID32300106
PMCPMC7162847

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.